Tested improved radiation targeting for children with ependymoma
Part of Cancer clinical trials.
This early-phase study tests a more precisely targeted type of radiation for children with ependymoma, aiming to treat the brain tumor more accurately. It may help reduce how much healthy tissue gets radiation, and researchers are checking safety and best dosing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has been diagnosed by pathology as ependymoma (WHO grade 2 or 3)
- The tumor is only in the brain—no signs it has spread to the spine on MRI or spinal fluid testing
- Your child cannot be receiving chemotherapy at the same time as radiation
- Your child must be able to have MRI scans, including using contrast dye
- Your child’s daily functioning should be fairly good (Lansky score 50–100)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to treat children with brain tumors using proton radiation (a precise type of radiation). It's designed to help the radiation target the tumor while protecting the spine and its ability to grow normally.
This trial tests a combination of two oral drugs (axitinib and metronomic etoposide) for children and young adults whose medulloblastoma or ependymoma has come back or is not responding to standard therapy. The goal is to see if this daily pill treatment can control tumor growth with manageable side effects.
This trial studies proton radiation therapy for adults with certain benign or slow-growing brain tumors. It aims to see how well tumors can be controlled, and how treatment affects quality of life and side effects.
This trial tests different follow-up treatments for children with brain ependymoma after their initial surgery. Which treatment you get depends on how much tumor is left (if any) and whether the child can safely receive radiation and chemotherapy.
This trial looks at why ependymoma can resist (be harder to treat) after radiation or treatment. It studies children who are already being followed in specific existing programs, which may help researchers find better treatment approaches in the future.
This trial tests if a precise type of radiation called proton therapy is safe and effective for children with certain brain tumors. It aims to reduce side effects by focusing radiation only on the tumor.
Hear when a new Ependymoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.